93 related articles for article (PubMed ID: 30478893)
1. A novel infram deletion in MSH6 gene in glioma: Conversation on MSH6 mutations in brain tumors.
Deris Zayeri Z; Tahmasebi Birgani M; Mohammadi Asl J; Kashipazha D; Hajjari M
J Cell Physiol; 2019 Jul; 234(7):11092-11102. PubMed ID: 30478893
[TBL] [Abstract][Full Text] [Related]
2. Novel MSH6 mutations in treatment-naïve glioblastoma and anaplastic oligodendroglioma contribute to temozolomide resistance independently of MGMT promoter methylation.
Nguyen SA; Stechishin OD; Luchman HA; Lun XQ; Senger DL; Robbins SM; Cairncross JG; Weiss S
Clin Cancer Res; 2014 Sep; 20(18):4894-903. PubMed ID: 25078279
[TBL] [Abstract][Full Text] [Related]
3. A high frequency of MSH6 G268A polymorphism and survival association in glioblastoma.
Pei C; Chen H; Jia X; Yan L; Zou Y; Jiang C; Jin H; Kang C; Jiang T; Ren H
Int J Neurosci; 2013 Feb; 123(2):114-20. PubMed ID: 23057844
[TBL] [Abstract][Full Text] [Related]
4. Constitutional mismatch repair-deficiency and whole-exome sequencing as the means of the rapid detection of the causative MSH6 defect.
Hoell JI; Gombert M; Ginzel S; Loth S; Landgraf P; Käfer V; Streiter M; Prokop A; Weiss M; Thiele R; Borkhardt A
Klin Padiatr; 2014 Nov; 226(6-7):357-61. PubMed ID: 25431869
[TBL] [Abstract][Full Text] [Related]
5. Constitutional Mismatch Repair Deficiency in Israel: High Proportion of Founder Mutations in MMR Genes and Consanguinity.
Baris HN; Barnes-Kedar I; Toledano H; Halpern M; Hershkovitz D; Lossos A; Lerer I; Peretz T; Kariv R; Cohen S; Half EE; Magal N; Drasinover V; Wimmer K; Goldberg Y; Bercovich D; Levi Z
Pediatr Blood Cancer; 2016 Mar; 63(3):418-27. PubMed ID: 26544533
[TBL] [Abstract][Full Text] [Related]
6. A homozygous mutation in MSH6 causes Turcot syndrome.
Hegde MR; Chong B; Blazo ME; Chin LH; Ward PA; Chintagumpala MM; Kim JY; Plon SE; Richards CS
Clin Cancer Res; 2005 Jul; 11(13):4689-93. PubMed ID: 16000562
[TBL] [Abstract][Full Text] [Related]
7. MSH6 and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer.
Huang J; Kuismanen SA; Liu T; Chadwick RB; Johnson CK; Stevens MW; Richards SK; Meek JE; Gao X; Wright FA; Mecklin JP; Järvinen HJ; Grönberg H; Bisgaard ML; Lindblom A; Peltomäki P
Cancer Res; 2001 Feb; 61(4):1619-23. PubMed ID: 11245474
[TBL] [Abstract][Full Text] [Related]
8. Heterogenous MSH6 loss is a result of microsatellite instability within MSH6 and occurs in sporadic and hereditary colorectal and endometrial carcinomas.
Graham RP; Kerr SE; Butz ML; Thibodeau SN; Halling KC; Smyrk TC; Dina MA; Waugh VM; Rumilla KM
Am J Surg Pathol; 2015 Oct; 39(10):1370-6. PubMed ID: 26099011
[TBL] [Abstract][Full Text] [Related]
9. ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts.
Yuan AL; Ricks CB; Bohm AK; Lun X; Maxwell L; Safdar S; Bukhari S; Gerber A; Sayeed W; Bering EA; Pedersen H; Chan JA; Shen Y; Marra M; Kaplan DR; Mason W; Goodman LD; Ezhilarasan R; Kaufmann AB; Cabral M; Robbins SM; Senger DL; Cahill DP; Sulman EP; Cairncross JG; Blough MD
PLoS One; 2018; 13(8):e0202860. PubMed ID: 30153289
[TBL] [Abstract][Full Text] [Related]
10. Association of MSH6 mutation with glioma susceptibility, drug resistance and progression.
Xie C; Sheng H; Zhang N; Li S; Wei X; Zheng X
Mol Clin Oncol; 2016 Aug; 5(2):236-240. PubMed ID: 27446556
[TBL] [Abstract][Full Text] [Related]
11. A homozygous MSH6 mutation in a child with café-au-lait spots, oligodendroglioma and rectal cancer.
Menko FH; Kaspers GL; Meijer GA; Claes K; van Hagen JM; Gille JJ
Fam Cancer; 2004; 3(2):123-7. PubMed ID: 15340263
[TBL] [Abstract][Full Text] [Related]
12. Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree.
Wagner A; Hendriks Y; Meijers-Heijboer EJ; de Leeuw WJ; Morreau H; Hofstra R; Tops C; Bik E; Bröcker-Vriends AH; van Der Meer C; Lindhout D; Vasen HF; Breuning MH; Cornelisse CJ; van Krimpen C; Niermeijer MF; Zwinderman AH; Wijnen J; Fodde R
J Med Genet; 2001 May; 38(5):318-22. PubMed ID: 11333868
[TBL] [Abstract][Full Text] [Related]
13. Delineating a new feature of constitutional mismatch repair deficiency (CMMRD) syndrome: breast cancer.
Bush L; Aronson M; Tabori U; Campbell BB; Bedgood RB; Jasperson K
Fam Cancer; 2019 Jan; 18(1):105-108. PubMed ID: 29785566
[TBL] [Abstract][Full Text] [Related]
14. IDH mutation and 1p19q codeletion distinguish two radiological patterns of diffuse low-grade gliomas.
Darlix A; Deverdun J; Menjot de Champfleur N; Castan F; Zouaoui S; Rigau V; Fabbro M; Yordanova Y; Le Bars E; Bauchet L; Gozé C; Duffau H
J Neurooncol; 2017 May; 133(1):37-45. PubMed ID: 28434111
[TBL] [Abstract][Full Text] [Related]
15. Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics.
Izquierdo C; Alentorn A; Idbaih A; Simó M; Kaloshi G; Ricard D; Barritault M; Meyronet D; Bruna J; Honnorat J; Delattre JY; Ducray F
J Neurooncol; 2018 Feb; 136(3):533-539. PubMed ID: 29143276
[TBL] [Abstract][Full Text] [Related]
16. High-grade brain tumors in siblings with biallelic MSH6 mutations.
Ilencikova D; Sejnova D; Jindrova J; Babal P
Pediatr Blood Cancer; 2011 Dec; 57(6):1067-70. PubMed ID: 21674763
[TBL] [Abstract][Full Text] [Related]
17. Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis.
Erson-Omay EZ; Çağlayan AO; Schultz N; Weinhold N; Omay SB; Özduman K; Köksal Y; Li J; Serin Harmancı A; Clark V; Carrión-Grant G; Baranoski J; Çağlar C; Barak T; Coşkun S; Baran B; Köse D; Sun J; Bakırcıoğlu M; Moliterno Günel J; Pamir MN; Mishra-Gorur K; Bilguvar K; Yasuno K; Vortmeyer A; Huttner AJ; Sander C; Günel M
Neuro Oncol; 2015 Oct; 17(10):1356-64. PubMed ID: 25740784
[TBL] [Abstract][Full Text] [Related]
18. Radiological characteristics based on isocitrate dehydrogenase mutations and 1p/19q codeletion in grade II and III gliomas.
Yamauchi T; Ohno M; Matsushita Y; Takahashi M; Miyakita Y; Kitagawa Y; Kondo E; Tsushita N; Satomi K; Yoshida A; Ichimura K; Narita Y
Brain Tumor Pathol; 2018 Jul; 35(3):148-158. PubMed ID: 29922974
[TBL] [Abstract][Full Text] [Related]
19. Childhood brain tumours due to germline bi-allelic mismatch repair gene mutations.
Johannesma PC; van der Klift HM; van Grieken NC; Troost D; Te Riele H; Jacobs MA; Postma TJ; Heideman DA; Tops CM; Wijnen JT; Menko FH
Clin Genet; 2011 Sep; 80(3):243-55. PubMed ID: 21261604
[TBL] [Abstract][Full Text] [Related]
20. An analysis of 170 glioma patients and systematic review to investigate the association between IDH-1 mutations and preoperative glioma-related epilepsy.
Yang Y; Mao Q; Wang X; Liu Y; Mao Y; Zhou Q; Luo J
J Clin Neurosci; 2016 Sep; 31():56-62. PubMed ID: 27406953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
